🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial teste...
Status
Completed
Location
Multiple Locations
Start Date
1997-09-27
Trial ID
NCT06395194
Treatments Being Tested
The purpose of the study is to see how two classes of blood pressure medica...
Status
Terminated
Location
Vanderbilt University Medical Center
Start Date
2010-01
Trial ID
NCT00878969
Treatments Being Tested
This study will evaluate the tolerability and safety of valsartan in patien...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-12
Trial ID
NCT00294086
Treatments Being Tested
The primary objective of the study is to determine whether, in patients wit...
Status
Completed
Location
Cedars-Sinai Heart Institute
Start Date
2017-03-02
Trial ID
NCT02816736
Treatments Being Tested
Sacubitril/Valsartan (SAC/VAL) is a new treatment of congestive heart failu...
Status
Completed
Location
Andalusia Hospitals
Start Date
2018-12-01
Trial ID
NCT03893435
Treatments Being Tested
To evaluate the efficacy and safety of aliskiren alone and in combination w...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-06
Trial ID
NCT00219180
Treatments Being Tested
The goal of this clinical trial is to learn whether valsartan can slow the ...
Status
Recruiting
Location
Institut universitaire de cardiologie et de pneumologie de Québec-ULaval
Start Date
2026-07-13
Trial ID
NCT07539298
One hundred twenty patients with arterial hypertension and albuminuria (som...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2004-07
Trial ID
NCT00171353
Treatments Being Tested
The purpose of this study was to evaluate the effect of LCZ696 compared to ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-18
Trial ID
NCT01920711
The primary aim of the trial is to compare telmisartan 80 mg to valsartan 1...
Status
Completed
Location
Multiple Locations
Start Date
2001-09
Trial ID
NCT02242318
Treatments Being Tested